Review: sepsis guidelines and core measure bundles.

{"article_title":"Review: sepsis guidelines and core measure bundles.","author":"Desposito, Lia , Bascara, Christina","journal_title":"Postgraduate medicine","issn":"1941-9260 ; Electronic","isbn":"","publication_date":"20240901","volume":"136","issue":"7","first_page":"702","page_count":"10","accession_number":"39092891","doi":"10.1080\/00325481.2024.2388021","publisher":"Informa Healthcare","doctype":"Journal Article; Review","subjects":"Intensive Care Medicine","interest_area":["Emergency Medicine"," Infectious Disease & Vaccines"," Immunology Allergy & Inflammation"],"abstract":"Sepsis is a major cause of mortality worldwide and is the third-leading cause of death in the United States. Sepsis is resource-intensive and requires prompt recognition and treatment to reduce mortality. The impact of sepsis is not only on in-hospital survival but extends into post-discharge quality of life and risk of re-admission. As the understanding of sepsis physiology evolved, so have the recommended screening tools and treatment protocol which challenge prior standards of care. There have been noteworthy efforts by the Surviving Sepsis Campaign, the Third International Consensus Definitions for Sepsis and the Centers for Medicare and Medicaid Services to establish core measure bundles. This review highlights both the 2021 SSC International Guidelines and the 2015 CMS Severe Sepsis\/Septic Shock Core Measure Bundle, or SEP-1. Notably, the SEP-1 bundle was implemented as a value-based purchasing program, linking care of sepsis patients to financial incentives. The objective is to explore the most current evidence-based data to inform clinical practice while utilizing the available guidelines as a roadmap.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=39092891&authtype=shib&custid=ns346513"}